Synthesis of Microfluidic-Based Nanoparticles and Their Potential Applications in Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 49
Special Issue Editors
Interests: vesicular system; drug delivery; transdermal drug delivery; colloidal systems; drug targeting; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: liposomes; niosomes; polymeric nanoparticles; transdermal drug delivery; drug targeting
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanoparticles (NPs) possess immense potential to revolutionize drug delivery by improving the specificity, efficacy, and safety of treatments, with them becoming a significant focal point in the field of drug delivery due to their unique properties. Various NPs have been developed to address different challenges in drug delivery, including poor drug solubility, poor bioavailability, inherent drug instability, severe adverse effects, and a lack of targeted delivery.
The types of nanoparticles used for this purpose are different, such as polymeric nanoparticles, liposomes, niosomes, and solid lipid nanoparticles. The preparation methods of nanoparticles play a crucial role in determining their size, shape, surface properties, and functionality, which affects their effectiveness in drug delivery.
Traditional NP synthesis bulk methods suffer from limitations such as less control over particle size and polydispersity (PDI), poor batch-to-batch reproducibility, and difficulties in scaling up production. The microfluidic method for the preparation of nanoparticles represents a significant advancement in the field of nanotechnology, offering precise control over the synthesis process and enabling the production of high-quality nanoparticles for various applications, particularly in drug delivery.
The following Special Issue aims to shed light on the latest advances in the preparation of nanoparticles with particular attention paid to microfluidics, to provide a collection of valuable information in not only the pharmaceutical field but other fields as well. We will explore how these innovative approaches can improve the stability and reproducibility of nanotechnology formulations.
Prof. Dr. Rita Muzzalupo
Dr. Elisabetta Mazzotta
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microfluidics
- lipids
- nanomedicine
- nanoparticles
- drug delivery
- polymers
